Evercore ISI initiated coverage of Summit Therapeutics (SMMT) with an Outperform rating and $30 price target The firm sees lead asset, ...
White T-shirts get a lot of attention, but let’s not forget their equally versatile counterpart: the exceedingly wearable, deceptively simple black T-shirt. It’s a staple you can wear to work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback